## Introduction
Pancreatic cancer presents one of the most significant challenges in modern oncology, largely due to the pancreas's complex anatomical location. Nestled deep in the retroperitoneum, it is surrounded by critical blood vessels that supply the body's digestive organs. A tumor's encroachment upon this vital vascular infrastructure is the central factor determining whether a potentially curative surgery is possible. This creates a critical knowledge gap: how do clinicians systematically decide who is a candidate for surgery? The National Comprehensive Cancer Network (NCCN) provides a sophisticated framework to answer this question, translating complex radiographic findings into a clear, strategic guide for treatment.

This article illuminates the logic and application of these crucial criteria. First, under "Principles and Mechanisms," we will dissect the anatomical and geometric rules that form the foundation of the NCCN framework, explaining the critical distinction between arterial and venous involvement. Following this, the "Applications and Interdisciplinary Connections" section will explore how these principles are put into practice, demonstrating that the criteria are not a static verdict but a dynamic language that unites a multidisciplinary team—from radiologists to surgeons—in a collaborative campaign to offer each patient the best possible outcome.

## Principles and Mechanisms

To understand the strategy for confronting pancreatic cancer, we must first appreciate the battlefield. The pancreas is not an isolated organ floating in space; it is nestled deep within the abdomen in a crowded, high-value neighborhood called the retroperitoneum. Think of this not as an open field but as a dense urban center, where the pancreas is a building tightly packed against critical infrastructure. This infrastructure includes the body’s major vascular “superhighways”—the great arteries and veins that supply the entire [digestive system](@entry_id:154289) [@problem_id:4652286].

Unlike tumors in more spacious locations that might simply grow into a large, round ball and push things aside, a pancreatic tumor has very little room to maneuver. It expands by infiltrating the surrounding tissues, like ivy growing into the cracks of a brick wall. And the structures it encounters first are often these vital blood vessels. This early and intimate relationship between the tumor and the vessels is the central challenge in pancreatic cancer surgery. The entire framework of resectability is, at its heart, a sophisticated system for answering a single, crucial question: has the tumor’s infiltration gone too far for a surgeon to safely and completely remove it?

### The Language of Invasion: Reading the Maps

Before a surgeon ever makes an incision, they rely on high-resolution maps of the battlefield provided by technologies like multiphasic Computed Tomography (CT). These scans give us a cross-sectional view of the anatomy, allowing us to see the tumor’s relationship to the surrounding vessels. To communicate these findings with precision, surgeons and radiologists have developed a standardized geometric language.

Imagine looking at a vessel in cross-section on a CT scan; it appears as a circle. The tumor’s contact with this vessel can be measured as an arc along the circle's circumference. This angle of contact is the fundamental unit of our language. We distinguish between two key situations [@problem_id:4652291]:

*   **Abutment:** The tumor is in contact with the vessel over an arc of $180^\circ$ or less.
*   **Encasement:** The tumor is in contact with the vessel over an arc of more than $180^\circ$.

Why is the $180^\circ$ mark so critical? It’s a geometric tipping point. If a tumor is touching less than half of a vessel’s circumference, one can imagine a surgeon skillfully finding a plane to dissect the tumor away from the vessel. But once the tumor wraps around more than half of the vessel, it has effectively captured it. There is no longer a simple path around; the tumor is on all sides. This radiographic finding is a powerful proxy for true invasion of the vessel wall.

The application of this rule is a matter of careful geometry. On a CT scan showing a tumor against the Superior Mesenteric Artery (SMA), a radiologist might measure the artery’s radius to be $2.5 \, \text{mm}$ and the arc of tumor contact to be $9.0 \, \text{mm}$. Using the simple geometric formula relating arc length ($s$), radius ($r$), and angle ($\theta$)—$s = r\theta$—we can calculate the angle of contact:
$$ \theta = \frac{s}{r} = \frac{9.0 \, \text{mm}}{2.5 \, \text{mm}} = 3.6 \, \text{radians} $$
Converting this to degrees ($3.6 \times \frac{180^\circ}{\pi}$) gives us approximately $206^\circ$. This single measurement, which is greater than $180^\circ$, classifies the involvement as **encasement** and dramatically alters the patient’s treatment path [@problem_id:5162466]. This highlights how critical precision is; a slight miscalculation or inconsistent measurement technique near the $180^\circ$ threshold could mistakenly shift a classification from borderline resectable to unresectable, or vice versa, with profound consequences for the patient [@problem_id:4604917].

### A Tale of Two Vessels: The Critical Distinction Between Arteries and Veins

While the $180^\circ$ rule is a powerful starting point, it is not applied uniformly. The type of vessel involved is just as important as the degree of contact. In the landscape of the retroperitoneum, arteries are not the same as veins.

#### Arteries: The Unforgiving Supply Lines

The major arteries near the pancreas—the **celiac axis (CA)** and the **superior mesenteric artery (SMA)**—are the non-negotiable lifelines for the liver, stomach, spleen, and the entirety of the small and large intestines. They are high-pressure, muscular conduits. When a CT scan shows that a tumor *encases* one of these arteries ($>180^\circ$), it strongly implies that the cancer has invaded the tough arterial wall.

The fundamental goal of cancer surgery is to achieve a **margin-negative (R0) resection**, meaning the removal of all tumor cells, both visible and microscopic [@problem_id:4652263]. If a tumor has invaded the SMA, simply peeling it off would leave microscopic cancer cells behind (an R1 resection), dooming the operation to failure from the start. The only way to achieve an R0 resection would be to cut out the involved segment of the artery itself. However, resecting and reconstructing the SMA or celiac axis is an extraordinarily high-risk procedure, fraught with potential for catastrophic complications like bowel or liver death, and it is not considered a standard procedure for pancreatic cancer.

Therefore, the oncologic principle is clear and unforgiving: encasement ($> 180^\circ$) of the SMA or celiac axis is a definitive sign that a curative resection is not technically feasible. This defines the tumor as **Locally Advanced (Unresectable)** [@problem_id:5162501].

#### Veins: The Resilient Return Path

The story is different for the major veins, primarily the **superior mesenteric vein (SMV)** and the **portal vein (PV)**. These vessels are the "return highways," collecting nutrient-rich blood from the intestines and carrying it to the liver. They are lower-pressure vessels with thinner, more pliable walls. Over decades of experience, surgeons have developed reliable techniques to resect a segment of an invaded vein and reconstruct it, either by sewing the two ends back together or by inserting a graft from another part of the body.

This technical feasibility completely changes the calculus. If a tumor encases the portal vein, even by $240^\circ$, it does not automatically mean the battle is lost. As long as there are healthy, uninvolved segments of the vein above and below the tumor to serve as anchors for reconstruction, a curative surgery is still on the table. The venous involvement makes the operation significantly more complex and risky, but not impossible [@problem_id:5160982]. This critical distinction is why venous encasement often places a tumor in the **Borderline Resectable** category, not the unresectable one.

### The Rules of Engagement: Defining Resectability

By combining our understanding of anatomy, the geometry of invasion, and the crucial differences between arteries and veins, we can now assemble the NCCN resectability criteria into a coherent strategic framework [@problem_id:5162473] [@problem_id:5179882]. For a tumor without distant spread (metastasis), the local status is classified into one of three categories:

1.  **Resectable (Green Light):** The path to surgery is clear. There is no contact with the critical arteries (SMA, CA, CHA), and any contact with the SMV/PV is less than $180^\circ$ and does not deform the vein. An upfront surgical resection is the standard approach.

2.  **Borderline Resectable (Yellow Light):** A curative resection may be possible, but there are significant technical hurdles. This is the category for tumors that "toe the line." It includes cases with:
    *   Arterial **abutment** ($\le 180^\circ$) of the SMA or CA.
    *   Venous **encasement** ($> 180^\circ$) or occlusion of the SMV/PV that appears technically reconstructible.
    *   Involvement of an aberrant but essential artery (like a replaced right hepatic artery) that could potentially be resected and reconstructed [@problem_id:5162437].
    The strategy here is not to rush to the operating room. Instead, these patients typically receive **neoadjuvant therapy** (chemotherapy, often with radiation) *before* surgery. The goal is to shrink the tumor, pull it back from the vessels, and turn a "yellow light" situation into a "green light," thereby increasing the chance of a successful R0 resection [@problem_id:4652263].

3.  **Locally Advanced / Unresectable (Red Light):** A curative surgery is not feasible with standard techniques. This classification is primarily defined by:
    *   Arterial **encasement** ($> 180^\circ$) of the SMA or CA.
    *   Unreconstructible occlusion of the SMV/PV.
    For these patients, the primary treatment is systemic therapy (chemotherapy) and/or radiation, not surgery.

These criteria are not arbitrary rules. They are a deeply logical and empirically validated system that translates complex anatomical and radiographic findings into a practical, risk-stratified guide for treatment. It is a beautiful example of how medicine integrates anatomy, geometry, and surgical experience into a unified strategy to give each patient the best possible chance of a cure.